

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | interferon-gamma production (GO:0032609) | 6.02256683 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.49260092 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.49260092 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.42336477 |
| 5 | negative T cell selection (GO:0043383) | 5.20436886 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.18971591 |
| 7 | negative thymic T cell selection (GO:0045060) | 5.04785858 |
| 8 | response to interleukin-15 (GO:0070672) | 4.95156915 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.76392413 |
| 10 | cellular response to interleukin-15 (GO:0071350) | 4.61891791 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.54625186 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.50254689 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.40442628 |
| 14 | negative regulation of cell killing (GO:0031342) | 4.40442628 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.35979425 |
| 16 | positive T cell selection (GO:0043368) | 4.34473174 |
| 17 | ribosomal small subunit assembly (GO:0000028) | 4.30231500 |
| 18 | thymic T cell selection (GO:0045061) | 4.30008756 |
| 19 | tolerance induction (GO:0002507) | 4.24277336 |
| 20 | T cell selection (GO:0045058) | 4.08408111 |
| 21 | leukocyte aggregation (GO:0070486) | 3.97949469 |
| 22 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.95647409 |
| 23 | mast cell activation (GO:0045576) | 3.93315586 |
| 24 | germinal center formation (GO:0002467) | 3.93297593 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.91997163 |
| 26 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.91116329 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.90199858 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.90199858 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.90199858 |
| 30 | positive regulation by symbiont of host defense response (GO:0052509) | 3.90199858 |
| 31 | modulation by symbiont of host defense response (GO:0052031) | 3.90199858 |
| 32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.90199858 |
| 33 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.86665868 |
| 34 | T cell migration (GO:0072678) | 3.85657338 |
| 35 | * B cell homeostasis (GO:0001782) | 3.68073855 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.64447550 |
| 37 | viral transcription (GO:0019083) | 3.63709058 |
| 38 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.60661729 |
| 39 | definitive hemopoiesis (GO:0060216) | 3.58937077 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.54714266 |
| 41 | regulation of T cell tolerance induction (GO:0002664) | 3.54326807 |
| 42 | T cell receptor signaling pathway (GO:0050852) | 3.49425046 |
| 43 | histone H3-K36 demethylation (GO:0070544) | 3.49316887 |
| 44 | Peyers patch development (GO:0048541) | 3.49293273 |
| 45 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.49293273 |
| 46 | * CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.49063257 |
| 47 | negative regulation of phagocytosis (GO:0050765) | 3.46901084 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.44425339 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.43389309 |
| 50 | translational termination (GO:0006415) | 3.41117796 |
| 51 | alpha-beta T cell activation (GO:0046631) | 3.40987501 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.40783161 |
| 53 | mature B cell differentiation (GO:0002335) | 3.36278434 |
| 54 | alpha-beta T cell differentiation (GO:0046632) | 3.36152477 |
| 55 | positive regulation of granulocyte differentiation (GO:0030854) | 3.35998798 |
| 56 | defense response to protozoan (GO:0042832) | 3.35845133 |
| 57 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.33294408 |
| 58 | * B cell proliferation (GO:0042100) | 3.31796325 |
| 59 | * antigen receptor-mediated signaling pathway (GO:0050851) | 3.29933016 |
| 60 | mast cell activation involved in immune response (GO:0002279) | 3.29894526 |
| 61 | mast cell degranulation (GO:0043303) | 3.29894526 |
| 62 | * T cell differentiation (GO:0030217) | 3.29599682 |
| 63 | regulation of regulatory T cell differentiation (GO:0045589) | 3.28408169 |
| 64 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.26047099 |
| 65 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.25547047 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.24766960 |
| 67 | response to muramyl dipeptide (GO:0032495) | 3.24712808 |
| 68 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.19011986 |
| 69 | * T cell homeostasis (GO:0043029) | 3.18528931 |
| 70 | positive regulation of isotype switching (GO:0045830) | 3.18241857 |
| 71 | positive regulation of humoral immune response (GO:0002922) | 3.17039128 |
| 72 | T cell costimulation (GO:0031295) | 3.15037253 |
| 73 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.14786029 |
| 74 | negative regulation of B cell proliferation (GO:0030889) | 3.12765510 |
| 75 | * regulation of B cell proliferation (GO:0030888) | 3.12136928 |
| 76 | myeloid dendritic cell activation (GO:0001773) | 3.11804472 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.10878174 |
| 78 | detection of bacterium (GO:0016045) | 3.10763348 |
| 79 | lymphocyte costimulation (GO:0031294) | 3.10418492 |
| 80 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.06586671 |
| 81 | positive regulation of macrophage differentiation (GO:0045651) | 3.05335752 |
| 82 | positive regulation of B cell differentiation (GO:0045579) | 3.04657071 |
| 83 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.04556953 |
| 84 | detection of other organism (GO:0098543) | 3.04208740 |
| 85 | regulation of granulocyte differentiation (GO:0030852) | 3.02126067 |
| 86 | regulation of histone H3-K27 methylation (GO:0061085) | 3.01804519 |
| 87 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.01622577 |
| 88 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.01490292 |
| 89 | * positive regulation of B cell activation (GO:0050871) | 3.00981423 |
| 90 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.00347104 |
| 91 | N-acetylneuraminate metabolic process (GO:0006054) | 2.99319182 |
| 92 | regulation of alpha-beta T cell activation (GO:0046634) | 2.99084738 |
| 93 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.98525818 |
| 94 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.95836638 |
| 95 | negative regulation of T cell mediated immunity (GO:0002710) | 2.94035072 |
| 96 | positive regulation of DNA recombination (GO:0045911) | 2.93420143 |
| 97 | * positive regulation of B cell proliferation (GO:0030890) | 2.93417240 |
| 98 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92501050 |
| 99 | * B cell receptor signaling pathway (GO:0050853) | 2.92167079 |
| 100 | natural killer cell differentiation (GO:0001779) | 2.91509274 |
| 101 | histone H3-K4 trimethylation (GO:0080182) | 2.91410290 |
| 102 | activated T cell proliferation (GO:0050798) | 2.91318517 |
| 103 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.90559630 |
| 104 | immunoglobulin mediated immune response (GO:0016064) | 2.89899107 |
| 105 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89833992 |
| 106 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.87943678 |
| 107 | positive regulation of tolerance induction (GO:0002645) | 2.87856861 |
| 108 | lymph node development (GO:0048535) | 2.87054886 |
| 109 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.84759123 |
| 110 | positive regulation of defense response to virus by host (GO:0002230) | 2.84548614 |
| 111 | positive regulation of interleukin-2 production (GO:0032743) | 2.84263079 |
| 112 | * regulation of B cell activation (GO:0050864) | 2.82579252 |
| 113 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.82413213 |
| 114 | * T cell lineage commitment (GO:0002360) | 2.82333788 |
| 115 | megakaryocyte development (GO:0035855) | 2.82203889 |
| 116 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.82089878 |
| 117 | cotranslational protein targeting to membrane (GO:0006613) | 2.80808908 |
| 118 | response to type I interferon (GO:0034340) | 2.80659691 |
| 119 | myeloid dendritic cell differentiation (GO:0043011) | 2.80168997 |
| 120 | regulation of isotype switching (GO:0045191) | 2.79784144 |
| 121 | protein targeting to ER (GO:0045047) | 2.79103471 |
| 122 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.78510044 |
| 123 | positive regulation of interferon-alpha production (GO:0032727) | 2.78402614 |
| 124 | ribosomal small subunit biogenesis (GO:0042274) | 2.78222955 |
| 125 | * T cell activation (GO:0042110) | 2.77845212 |
| 126 | regulation of RIG-I signaling pathway (GO:0039535) | 2.76827364 |
| 127 | response to host immune response (GO:0052572) | 2.76421335 |
| 128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76421335 |
| 129 | natural killer cell activation (GO:0030101) | 2.76333241 |
| 130 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76296212 |
| 131 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.76035832 |
| 132 | * lymphocyte homeostasis (GO:0002260) | 2.75663964 |
| 133 | type I interferon signaling pathway (GO:0060337) | 2.75611371 |
| 134 | cellular response to type I interferon (GO:0071357) | 2.75611371 |
| 135 | translational elongation (GO:0006414) | 2.75222325 |
| 136 | embryonic hemopoiesis (GO:0035162) | 2.74967963 |
| 137 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.74628274 |
| 138 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.74628274 |
| 139 | viral genome replication (GO:0019079) | 2.72022802 |
| 140 | * lymphocyte differentiation (GO:0030098) | 2.68500448 |
| 141 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.66898279 |
| 142 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.66082462 |
| 143 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.64336234 |
| 144 | positive regulation of B cell mediated immunity (GO:0002714) | 2.64336234 |
| 145 | viral life cycle (GO:0019058) | 2.63989567 |
| 146 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.63404945 |
| 147 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.61770731 |
| 148 | response to protozoan (GO:0001562) | 2.59846989 |
| 149 | regulation of response to interferon-gamma (GO:0060330) | 2.58603031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.61858083 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.27494533 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.58904238 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.91245517 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.59026125 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.68288200 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.56221853 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.54893205 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.44443554 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.38935708 |
| 11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.19197177 |
| 12 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.07854473 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 3.05193571 |
| 14 | * MYB_26560356_Chip-Seq_TH2_Human | 2.94427070 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.89846469 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.87040457 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67755867 |
| 18 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.54480004 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.52929863 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 2.48664895 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.42144669 |
| 22 | * MYB_26560356_Chip-Seq_TH1_Human | 2.41592089 |
| 23 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.30857229 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.28870135 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27399305 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25172865 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.22863244 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.20526682 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 2.19700440 |
| 30 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.10500847 |
| 31 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.05902641 |
| 32 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96765265 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.95995465 |
| 34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91071311 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88273364 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82410048 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80141559 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.80053405 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.74224825 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70681202 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69231568 |
| 42 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69192534 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.66517953 |
| 44 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62271016 |
| 45 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54374371 |
| 46 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.52347669 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.48057925 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48057681 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.43692787 |
| 50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40200353 |
| 51 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.39506185 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38315786 |
| 53 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37275227 |
| 54 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.35590858 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35146165 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.33774647 |
| 57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29703923 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28070097 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27392201 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26414370 |
| 61 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25598357 |
| 62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25479480 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25310015 |
| 64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.25285699 |
| 65 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20551462 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18976130 |
| 67 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.18248745 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16512336 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15258085 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14166340 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12292627 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11087665 |
| 73 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.07241184 |
| 74 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.06288865 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01594384 |
| 76 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.98954169 |
| 77 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97256555 |
| 78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.96425448 |
| 79 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96259194 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95602125 |
| 81 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95586561 |
| 82 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95316831 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94787241 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93239036 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92844284 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91680871 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85699464 |
| 88 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85624661 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82004256 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81906198 |
| 91 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.81549587 |
| 92 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80895848 |
| 93 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.80199627 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77238316 |
| 95 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75629592 |
| 96 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.74631343 |
| 97 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.72960585 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72249833 |
| 99 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70378241 |
| 100 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.70330353 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69650001 |
| 102 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69242087 |
| 103 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.68371413 |
| 104 | GATA3_26560356_Chip-Seq_TH1_Human | 0.67474853 |
| 105 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66632689 |
| 106 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.65639162 |
| 107 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65435792 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.65017736 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.63644988 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.63169220 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62720935 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.62155870 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.61805824 |
| 114 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.61216793 |
| 115 | * SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.58250600 |
| 116 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.56912416 |
| 117 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.56098985 |
| 118 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.54997612 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.54661963 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.53104621 |
| 121 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.52521138 |
| 122 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.51463065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0003763_abnormal_thymus_physiology | 4.32658184 |
| 2 | MP0005671_abnormal_response_to | 3.86103849 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.62057297 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.31421623 |
| 5 | MP0001800_abnormal_humoral_immune | 2.98140174 |
| 6 | MP0002166_altered_tumor_susceptibility | 2.93143293 |
| 7 | MP0002398_abnormal_bone_marrow | 2.69644503 |
| 8 | MP0000685_abnormal_immune_system | 2.63204755 |
| 9 | * MP0002420_abnormal_adaptive_immunity | 2.60021546 |
| 10 | MP0005387_immune_system_phenotype | 2.58937401 |
| 11 | MP0001790_abnormal_immune_system | 2.58937401 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.56357446 |
| 13 | * MP0001819_abnormal_immune_cell | 2.55263331 |
| 14 | MP0002006_tumorigenesis | 2.51333331 |
| 15 | MP0002723_abnormal_immune_serum | 2.50553917 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.43396686 |
| 17 | MP0002009_preneoplasia | 2.39707234 |
| 18 | MP0001873_stomach_inflammation | 2.38554292 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.32982052 |
| 20 | * MP0000703_abnormal_thymus_morphology | 2.32265439 |
| 21 | * MP0000716_abnormal_immune_system | 2.25852033 |
| 22 | MP0009785_altered_susceptibility_to | 2.24766762 |
| 23 | MP0005025_abnormal_response_to | 2.20777125 |
| 24 | MP0005174_abnormal_tail_pigmentation | 2.14656938 |
| 25 | * MP0000689_abnormal_spleen_morphology | 2.14004646 |
| 26 | * MP0002722_abnormal_immune_system | 2.13577547 |
| 27 | MP0003866_abnormal_defecation | 2.13071405 |
| 28 | MP0002405_respiratory_system_inflammati | 2.11217869 |
| 29 | MP0003436_decreased_susceptibility_to | 2.08766227 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 2.03776318 |
| 31 | * MP0005075_abnormal_melanosome_morpholog | 1.99431132 |
| 32 | MP0003724_increased_susceptibility_to | 1.98911732 |
| 33 | * MP0009333_abnormal_splenocyte_physiolog | 1.95891728 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.92700424 |
| 35 | MP0002933_joint_inflammation | 1.90067971 |
| 36 | MP0005409_darkened_coat_color | 1.89412944 |
| 37 | MP0002429_abnormal_blood_cell | 1.89339095 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.89008809 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.81848808 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.76046646 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.75878975 |
| 42 | MP0001853_heart_inflammation | 1.75646061 |
| 43 | * MP0002419_abnormal_innate_immunity | 1.73417505 |
| 44 | MP0005451_abnormal_body_composition | 1.68955601 |
| 45 | MP0000015_abnormal_ear_pigmentation | 1.58963050 |
| 46 | MP0009379_abnormal_foot_pigmentation | 1.57887697 |
| 47 | MP0002095_abnormal_skin_pigmentation | 1.56500208 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.54052018 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.47799763 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.47799763 |
| 51 | * MP0000490_abnormal_crypts_of | 1.46663551 |
| 52 | MP0003303_peritoneal_inflammation | 1.41982225 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.36984143 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.32748102 |
| 55 | MP0003045_fibrosis | 1.31758007 |
| 56 | MP0000858_altered_metastatic_potential | 1.30991261 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.21319601 |
| 58 | MP0010094_abnormal_chromosome_stability | 1.21201088 |
| 59 | MP0008057_abnormal_DNA_replication | 1.19940991 |
| 60 | MP0003091_abnormal_cell_migration | 1.19728585 |
| 61 | MP0001188_hyperpigmentation | 1.14150607 |
| 62 | MP0004947_skin_inflammation | 1.13310515 |
| 63 | MP0009278_abnormal_bone_marrow | 1.12372715 |
| 64 | MP0001986_abnormal_taste_sensitivity | 1.08315490 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.06094472 |
| 66 | MP0002132_abnormal_respiratory_system | 1.02066823 |
| 67 | * MP0004381_abnormal_hair_follicle | 1.00040169 |
| 68 | * MP0002019_abnormal_tumor_incidence | 0.99713848 |
| 69 | MP0009115_abnormal_fat_cell | 0.91657136 |
| 70 | MP0000569_abnormal_digit_pigmentation | 0.90297235 |
| 71 | MP0001533_abnormal_skeleton_physiology | 0.89739396 |
| 72 | MP0004130_abnormal_muscle_cell | 0.89510839 |
| 73 | MP0003448_altered_tumor_morphology | 0.89106264 |
| 74 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87145727 |
| 75 | MP0003172_abnormal_lysosome_physiology | 0.85834924 |
| 76 | MP0003943_abnormal_hepatobiliary_system | 0.85223030 |
| 77 | MP0008007_abnormal_cellular_replicative | 0.83795152 |
| 78 | MP0006082_CNS_inflammation | 0.82029550 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 0.81906787 |
| 80 | MP0001851_eye_inflammation | 0.80964711 |
| 81 | MP0008260_abnormal_autophagy | 0.79622897 |
| 82 | MP0002163_abnormal_gland_morphology | 0.79399180 |
| 83 | MP0001663_abnormal_digestive_system | 0.78832485 |
| 84 | MP0008058_abnormal_DNA_repair | 0.78331462 |
| 85 | MP0004510_myositis | 0.75537414 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.75376957 |
| 87 | MP0000383_abnormal_hair_follicle | 0.74885958 |
| 88 | MP0008469_abnormal_protein_level | 0.74723181 |
| 89 | MP0003077_abnormal_cell_cycle | 0.74296842 |
| 90 | MP0002938_white_spotting | 0.74019356 |
| 91 | MP0010307_abnormal_tumor_latency | 0.71806486 |
| 92 | MP0003136_yellow_coat_color | 0.70400083 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.69932408 |
| 94 | MP0000249_abnormal_blood_vessel | 0.69144747 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.67967457 |
| 96 | MP0003646_muscle_fatigue | 0.66553117 |
| 97 | MP0009764_decreased_sensitivity_to | 0.66233402 |
| 98 | MP0003795_abnormal_bone_structure | 0.65880260 |
| 99 | MP0002089_abnormal_postnatal_growth/wei | 0.65411524 |
| 100 | MP0005621_abnormal_cell_physiology | 0.62922630 |
| 101 | MP0000681_abnormal_thyroid_gland | 0.62652795 |
| 102 | MP0003693_abnormal_embryo_hatching | 0.61067008 |
| 103 | MP0002693_abnormal_pancreas_physiology | 0.60979228 |
| 104 | MP0001919_abnormal_reproductive_system | 0.60367830 |
| 105 | MP0004883_abnormal_blood_vessel | 0.59319373 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.59055376 |
| 107 | MP0008874_decreased_physiological_sensi | 0.57705545 |
| 108 | MP0002277_abnormal_respiratory_mucosa | 0.57122916 |
| 109 | MP0000350_abnormal_cell_proliferation | 0.56073677 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.55705573 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.54415990 |
| 112 | MP0006292_abnormal_olfactory_placode | 0.53363522 |
| 113 | * MP0000477_abnormal_intestine_morphology | 0.53340226 |
| 114 | MP0003868_abnormal_feces_composition | 0.52880960 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.52489281 |
| 116 | * MP0002075_abnormal_coat/hair_pigmentati | 0.52400102 |
| 117 | MP0005266_abnormal_metabolism | 0.51778340 |
| 118 | MP0005390_skeleton_phenotype | 0.51706160 |
| 119 | MP0003828_pulmonary_edema | 0.50225065 |
| 120 | MP0003453_abnormal_keratinocyte_physiol | 0.49709656 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.49334792 |
| 122 | MP0002928_abnormal_bile_duct | 0.48802962 |
| 123 | MP0000343_altered_response_to | 0.47978564 |
| 124 | MP0000428_abnormal_craniofacial_morphol | 0.47711389 |
| 125 | MP0002113_abnormal_skeleton_development | 0.47666941 |
| 126 | MP0009250_abnormal_appendicular_skeleto | 0.44197462 |
| 127 | MP0005310_abnormal_salivary_gland | 0.43858664 |
| 128 | MP0005023_abnormal_wound_healing | 0.42397672 |
| 129 | MP0000313_abnormal_cell_death | 0.41277183 |
| 130 | MP0010352_gastrointestinal_tract_polyps | 0.40702449 |
| 131 | MP0008569_lethality_at_weaning | 0.39806409 |
| 132 | MP0009763_increased_sensitivity_to | 0.39652425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IgM deficiency (HP:0002850) | 5.27888328 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.13453915 |
| 3 | Colitis (HP:0002583) | 5.07280507 |
| 4 | Chronic otitis media (HP:0000389) | 4.53869984 |
| 5 | T lymphocytopenia (HP:0005403) | 4.44380681 |
| 6 | Myositis (HP:0100614) | 4.43968415 |
| 7 | Abnormality of T cell number (HP:0011839) | 4.15349228 |
| 8 | Abnormality of T cells (HP:0002843) | 3.78137626 |
| 9 | Recurrent bronchitis (HP:0002837) | 3.71466395 |
| 10 | Recurrent viral infections (HP:0004429) | 3.67874714 |
| 11 | Selective tooth agenesis (HP:0001592) | 3.64728405 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.49881165 |
| 13 | Abnormality of the fingertips (HP:0001211) | 3.44356140 |
| 14 | Panhypogammaglobulinemia (HP:0003139) | 3.42796566 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.36835981 |
| 16 | Papilloma (HP:0012740) | 3.30493486 |
| 17 | Verrucae (HP:0200043) | 3.30493486 |
| 18 | Viral hepatitis (HP:0006562) | 3.29459710 |
| 19 | Stomatitis (HP:0010280) | 3.27978957 |
| 20 | IgG deficiency (HP:0004315) | 3.23841699 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.18711450 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.18711450 |
| 23 | Agammaglobulinemia (HP:0004432) | 3.16753062 |
| 24 | * Meningitis (HP:0001287) | 3.15480391 |
| 25 | Abnormality of the prostate (HP:0008775) | 3.14827719 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.10570087 |
| 27 | Thrombocytosis (HP:0001894) | 3.08009189 |
| 28 | Vasculitis (HP:0002633) | 2.87694325 |
| 29 | IgA deficiency (HP:0002720) | 2.86597746 |
| 30 | Lymphopenia (HP:0001888) | 2.86069851 |
| 31 | Emphysema (HP:0002097) | 2.83696398 |
| 32 | Optic neuritis (HP:0100653) | 2.82389078 |
| 33 | Retrobulbar optic neuritis (HP:0100654) | 2.82389078 |
| 34 | Nasal polyposis (HP:0100582) | 2.81169370 |
| 35 | Restrictive lung disease (HP:0002091) | 2.81117891 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.80767468 |
| 37 | Chronic diarrhea (HP:0002028) | 2.76529337 |
| 38 | Osteomyelitis (HP:0002754) | 2.71458131 |
| 39 | Basal cell carcinoma (HP:0002671) | 2.71323538 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.67521622 |
| 41 | Orchitis (HP:0100796) | 2.66432610 |
| 42 | Hypoplasia of the thymus (HP:0000778) | 2.62222346 |
| 43 | Petechiae (HP:0000967) | 2.57539656 |
| 44 | Obstructive lung disease (HP:0006536) | 2.50396721 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.50396721 |
| 46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.49842254 |
| 47 | * Lymphoma (HP:0002665) | 2.49580562 |
| 48 | Abnormal number of incisors (HP:0011064) | 2.48802721 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.48547937 |
| 50 | Reticulocytopenia (HP:0001896) | 2.47224539 |
| 51 | B lymphocytopenia (HP:0010976) | 2.43963654 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.43963654 |
| 53 | Inflammation of the large intestine (HP:0002037) | 2.43632878 |
| 54 | Fatigue (HP:0012378) | 2.43092425 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.39518513 |
| 56 | Sepsis (HP:0100806) | 2.38426798 |
| 57 | Spontaneous hematomas (HP:0007420) | 2.37916296 |
| 58 | Hemoptysis (HP:0002105) | 2.37358853 |
| 59 | Encephalitis (HP:0002383) | 2.36999206 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.36524229 |
| 61 | Severe combined immunodeficiency (HP:0004430) | 2.34637108 |
| 62 | Abnormality of the nasal mucosa (HP:0000433) | 2.33514421 |
| 63 | * Mediastinal lymphadenopathy (HP:0100721) | 2.33078710 |
| 64 | Abnormality of macrophages (HP:0004311) | 2.30173022 |
| 65 | Recurrent lower respiratory tract infections (HP:0002783) | 2.29880150 |
| 66 | Eosinophilia (HP:0001880) | 2.26151913 |
| 67 | Abnormality of eosinophils (HP:0001879) | 2.25567524 |
| 68 | Acute myeloid leukemia (HP:0004808) | 2.25544102 |
| 69 | Bronchitis (HP:0012387) | 2.23980917 |
| 70 | Abnormality of the columella (HP:0009929) | 2.22751160 |
| 71 | Eczematoid dermatitis (HP:0000976) | 2.22284525 |
| 72 | Slow saccadic eye movements (HP:0000514) | 2.22105508 |
| 73 | Abnormal number of erythroid precursors (HP:0012131) | 2.21922947 |
| 74 | Recurrent pneumonia (HP:0006532) | 2.21600933 |
| 75 | Increased IgM level (HP:0003496) | 2.19677081 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.18675393 |
| 77 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.18401302 |
| 78 | Hepatitis (HP:0012115) | 2.17529749 |
| 79 | Spinal cord lesions (HP:0100561) | 2.16779095 |
| 80 | Syringomyelia (HP:0003396) | 2.16779095 |
| 81 | Autoimmune hemolytic anemia (HP:0001890) | 2.15821637 |
| 82 | Chronic sinusitis (HP:0011109) | 2.15376112 |
| 83 | Prostate neoplasm (HP:0100787) | 2.11985997 |
| 84 | Pulmonary fibrosis (HP:0002206) | 2.11073257 |
| 85 | Gastrointestinal stroma tumor (HP:0100723) | 2.08373659 |
| 86 | Cellulitis (HP:0100658) | 2.07264162 |
| 87 | Thyroiditis (HP:0100646) | 2.07046748 |
| 88 | Recurrent sinusitis (HP:0011108) | 2.06415787 |
| 89 | Recurrent skin infections (HP:0001581) | 2.05303886 |
| 90 | Gingivitis (HP:0000230) | 2.05261156 |
| 91 | Short 4th metacarpal (HP:0010044) | 2.04023780 |
| 92 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.04023780 |
| 93 | Leukocytosis (HP:0001974) | 2.03920592 |
| 94 | Papilledema (HP:0001085) | 2.03635733 |
| 95 | Aplastic anemia (HP:0001915) | 2.02671581 |
| 96 | Epistaxis (HP:0000421) | 2.02279733 |
| 97 | Chest pain (HP:0100749) | 1.99458390 |
| 98 | Granulocytopenia (HP:0001913) | 1.98522158 |
| 99 | Dysmetric saccades (HP:0000641) | 1.98395960 |
| 100 | 11 pairs of ribs (HP:0000878) | 1.95279961 |
| 101 | Keratoconjunctivitis sicca (HP:0001097) | 1.93410898 |
| 102 | Thoracolumbar scoliosis (HP:0002944) | 1.93020888 |
| 103 | Basal ganglia calcification (HP:0002135) | 1.93019585 |
| 104 | Keratoconjunctivitis (HP:0001096) | 1.92835049 |
| 105 | Increased density of long bones (HP:0006392) | 1.92149697 |
| 106 | Pustule (HP:0200039) | 1.91854329 |
| 107 | Combined immunodeficiency (HP:0005387) | 1.91738159 |
| 108 | Leukopenia (HP:0001882) | 1.90850889 |
| 109 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.90240324 |
| 110 | Ureteral stenosis (HP:0000071) | 1.90063675 |
| 111 | Cheilitis (HP:0100825) | 1.89589228 |
| 112 | Recurrent bacterial skin infections (HP:0005406) | 1.89365447 |
| 113 | Hypergammaglobulinemia (HP:0010702) | 1.89210223 |
| 114 | Trigonocephaly (HP:0000243) | 1.87634890 |
| 115 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87305431 |
| 116 | Arterial thrombosis (HP:0004420) | 1.86717441 |
| 117 | Narrow palate (HP:0000189) | 1.85278799 |
| 118 | Increased IgE level (HP:0003212) | 1.84428291 |
| 119 | Recurrent otitis media (HP:0000403) | 1.81326540 |
| 120 | Pulmonary embolism (HP:0002204) | 1.81324688 |
| 121 | Acute lymphatic leukemia (HP:0006721) | 1.80581102 |
| 122 | Abnormality of the parietal bone (HP:0002696) | 1.80559734 |
| 123 | Arthralgia (HP:0002829) | 1.80553946 |
| 124 | Skin rash (HP:0000988) | 1.80423405 |
| 125 | Urticaria (HP:0001025) | 1.79188218 |
| 126 | Autoimmune thrombocytopenia (HP:0001973) | 1.79170238 |
| 127 | Abnormality of the incisor (HP:0000676) | 1.77403758 |
| 128 | Clubbing of toes (HP:0100760) | 1.76886278 |
| 129 | Skin ulcer (HP:0200042) | 1.76602048 |
| 130 | Midline defect of the nose (HP:0004122) | 1.74525428 |
| 131 | Joint swelling (HP:0001386) | 1.74261648 |
| 132 | Prominent nose (HP:0000448) | 1.74220503 |
| 133 | Subacute progressive viral hepatitis (HP:0006572) | 1.71581469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.06486976 |
| 2 | TXK | 4.85143212 |
| 3 | PRPF4B | 3.82375941 |
| 4 | RIPK4 | 3.78329569 |
| 5 | CLK1 | 3.04006079 |
| 6 | TEC | 2.67509882 |
| 7 | MKNK2 | 2.67085715 |
| 8 | JAK3 | 2.40812270 |
| 9 | ITK | 2.27349667 |
| 10 | KIT | 2.23629762 |
| 11 | ZAP70 | 2.22898268 |
| 12 | NME2 | 2.05733983 |
| 13 | BTK | 1.96826790 |
| 14 | NLK | 1.95957658 |
| 15 | TRIB3 | 1.90350939 |
| 16 | TYK2 | 1.87923714 |
| 17 | STK10 | 1.87075287 |
| 18 | IKBKE | 1.86935862 |
| 19 | CDK12 | 1.79896057 |
| 20 | EEF2K | 1.76589718 |
| 21 | FGFR3 | 1.69138990 |
| 22 | MKNK1 | 1.68978048 |
| 23 | IRAK4 | 1.65697220 |
| 24 | TNIK | 1.65134081 |
| 25 | MAP3K14 | 1.61988924 |
| 26 | SYK | 1.58455056 |
| 27 | SMG1 | 1.56496210 |
| 28 | LCK | 1.54599073 |
| 29 | JAK1 | 1.50409885 |
| 30 | FES | 1.45519216 |
| 31 | PIM1 | 1.45274381 |
| 32 | GRK6 | 1.41895213 |
| 33 | BMPR2 | 1.41663785 |
| 34 | TBK1 | 1.36462397 |
| 35 | HCK | 1.32820857 |
| 36 | MAPK11 | 1.32619827 |
| 37 | ERN1 | 1.30210391 |
| 38 | MUSK | 1.25128024 |
| 39 | IRAK3 | 1.24342133 |
| 40 | YES1 | 1.21258267 |
| 41 | MAPK12 | 1.18548586 |
| 42 | PASK | 1.18398389 |
| 43 | SIK3 | 1.17460184 |
| 44 | IKBKB | 1.16035349 |
| 45 | MST4 | 1.14962717 |
| 46 | MAP3K13 | 1.14786007 |
| 47 | FGFR4 | 1.14647499 |
| 48 | SRPK1 | 1.12867833 |
| 49 | TNK2 | 1.12759672 |
| 50 | TLK1 | 1.11425829 |
| 51 | MELK | 1.09088490 |
| 52 | HIPK2 | 1.08170814 |
| 53 | CSF1R | 1.00633256 |
| 54 | LRRK2 | 0.98099323 |
| 55 | LYN | 0.97687922 |
| 56 | SIK2 | 0.93303152 |
| 57 | CSK | 0.92080414 |
| 58 | IRAK1 | 0.89008919 |
| 59 | ICK | 0.87158365 |
| 60 | MAPK7 | 0.87120268 |
| 61 | CDC7 | 0.86938659 |
| 62 | BLK | 0.86534240 |
| 63 | PDK1 | 0.86221721 |
| 64 | PRKCQ | 0.85429326 |
| 65 | TAOK3 | 0.85416752 |
| 66 | EPHA3 | 0.84122725 |
| 67 | PIK3CG | 0.83250184 |
| 68 | RPS6KA4 | 0.83039026 |
| 69 | MAP3K10 | 0.81947152 |
| 70 | CAMKK1 | 0.81424919 |
| 71 | CDC42BPA | 0.79856399 |
| 72 | CDK4 | 0.78034287 |
| 73 | CHUK | 0.74439744 |
| 74 | VRK1 | 0.73941179 |
| 75 | MARK3 | 0.73493560 |
| 76 | TGFBR2 | 0.72598015 |
| 77 | PIM2 | 0.70226729 |
| 78 | SGK3 | 0.69486550 |
| 79 | PKN2 | 0.69484100 |
| 80 | CASK | 0.67171377 |
| 81 | PRKD2 | 0.66383893 |
| 82 | SIK1 | 0.65379565 |
| 83 | MAP2K3 | 0.64094839 |
| 84 | MAP3K7 | 0.63574139 |
| 85 | JAK2 | 0.62007604 |
| 86 | ATR | 0.61866774 |
| 87 | OBSCN | 0.61707707 |
| 88 | CDK6 | 0.57312290 |
| 89 | MAP3K1 | 0.55043016 |
| 90 | RPS6KA6 | 0.54744857 |
| 91 | CDK8 | 0.54740388 |
| 92 | TRPM7 | 0.53454881 |
| 93 | STK24 | 0.53041034 |
| 94 | FLT3 | 0.51236807 |
| 95 | CAMKK2 | 0.50659568 |
| 96 | MAP3K12 | 0.50453970 |
| 97 | STK4 | 0.49966672 |
| 98 | RET | 0.49346744 |
| 99 | STK16 | 0.49269947 |
| 100 | KDR | 0.49245360 |
| 101 | TGFBR1 | 0.48237524 |
| 102 | MAP2K6 | 0.47998742 |
| 103 | NEK9 | 0.45373479 |
| 104 | RPS6KB2 | 0.44091448 |
| 105 | SCYL2 | 0.43424661 |
| 106 | KSR2 | 0.41563836 |
| 107 | FGR | 0.40247040 |
| 108 | RPS6KC1 | 0.39641767 |
| 109 | RPS6KL1 | 0.39641767 |
| 110 | CDK9 | 0.39300030 |
| 111 | PDPK1 | 0.39100879 |
| 112 | UHMK1 | 0.38156079 |
| 113 | MATK | 0.38047898 |
| 114 | * MAPK4 | 0.37693686 |
| 115 | TAOK2 | 0.37060242 |
| 116 | MAP3K6 | 0.36636409 |
| 117 | CDK7 | 0.35724809 |
| 118 | SGK2 | 0.35240750 |
| 119 | BRD4 | 0.32488805 |
| 120 | WNK1 | 0.31914426 |
| 121 | NUAK1 | 0.30932326 |
| 122 | FYN | 0.30735073 |
| 123 | SGK223 | 0.30682183 |
| 124 | SGK494 | 0.30682183 |
| 125 | IRAK2 | 0.30622602 |
| 126 | ADRBK2 | 0.30314079 |
| 127 | RPS6KA5 | 0.29379482 |
| 128 | STK3 | 0.28913585 |
| 129 | CAMK4 | 0.28835343 |
| 130 | EIF2AK3 | 0.28173033 |
| 131 | TTN | 0.28158085 |
| 132 | PRKCH | 0.28117513 |
| 133 | RPS6KB1 | 0.28017903 |
| 134 | MAP2K2 | 0.27526036 |
| 135 | IGF1R | 0.27449897 |
| 136 | CAMK1 | 0.26600232 |
| 137 | MARK2 | 0.26486305 |
| 138 | EIF2AK2 | 0.25860521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.77063683 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.59338099 |
| 3 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.47703248 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.42539462 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.35316999 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.28817358 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.28477229 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.17461038 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.10573783 |
| 10 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02669603 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99477177 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91416687 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 1.87884759 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.80882050 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.73848167 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.70548672 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68925149 |
| 18 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63915039 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63789461 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.61962939 |
| 21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61946752 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.60629062 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60329466 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.52674863 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.51837093 |
| 26 | Base excision repair_Homo sapiens_hsa03410 | 1.48915459 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43118071 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.31161491 |
| 29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.30314892 |
| 30 | Spliceosome_Homo sapiens_hsa03040 | 1.29015408 |
| 31 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.25739378 |
| 32 | * Hepatitis B_Homo sapiens_hsa05161 | 1.25186102 |
| 33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.24227002 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23652964 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23445712 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19982706 |
| 37 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19265114 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.17406604 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15431228 |
| 40 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.08400666 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.07640655 |
| 42 | HTLV-I infection_Homo sapiens_hsa05166 | 1.06047659 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.05900175 |
| 44 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05189987 |
| 45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02249544 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01872300 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01547332 |
| 48 | Platelet activation_Homo sapiens_hsa04611 | 0.96771680 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95038177 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94746494 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93841934 |
| 52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.92229629 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90484364 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90370102 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88280639 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87614244 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87210293 |
| 58 | * Small cell lung cancer_Homo sapiens_hsa05222 | 0.86775694 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85477893 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84943029 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83902210 |
| 62 | Cell cycle_Homo sapiens_hsa04110 | 0.83422902 |
| 63 | RNA degradation_Homo sapiens_hsa03018 | 0.82278372 |
| 64 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81746996 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80906099 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80370577 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.79407115 |
| 68 | Shigellosis_Homo sapiens_hsa05131 | 0.77767080 |
| 69 | * Apoptosis_Homo sapiens_hsa04210 | 0.76577912 |
| 70 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.75354117 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74396584 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.73318865 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.72696866 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.71517857 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.71203394 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69514335 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68864745 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68287007 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64949837 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.64880835 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63571478 |
| 82 | * Colorectal cancer_Homo sapiens_hsa05210 | 0.62951385 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62430803 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62066347 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61157320 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.60169194 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59969964 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59817110 |
| 89 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59002400 |
| 90 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.57861056 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57401559 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.57142300 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55811168 |
| 94 | * Tuberculosis_Homo sapiens_hsa05152 | 0.55734864 |
| 95 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55519873 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55042988 |
| 97 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52939013 |
| 98 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52833727 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51566979 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51041410 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50688144 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48955808 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48025344 |
| 104 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47624720 |
| 105 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.45351523 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45255383 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44859714 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44507319 |
| 109 | * Prostate cancer_Homo sapiens_hsa05215 | 0.43592781 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43521037 |
| 111 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43484617 |
| 112 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41955909 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40873627 |
| 114 | Salmonella infection_Homo sapiens_hsa05132 | 0.40363244 |
| 115 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.40144217 |
| 116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39812578 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38619835 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38539163 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35066202 |
| 120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34922895 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.32905250 |
| 122 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.32252443 |
| 123 | Basal transcription factors_Homo sapiens_hsa03022 | 0.32222685 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32131154 |
| 125 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.29797214 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.28782587 |
| 127 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.27980410 |
| 128 | Lysine degradation_Homo sapiens_hsa00310 | 0.27219610 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26776117 |
| 130 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.26685369 |
| 131 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.24189395 |

